Condition
Anal Cancer Squamous Cell
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Not Yet Recruiting1
Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07464236Not ApplicableNot Yet Recruiting
Improving Clinic Delivery of HIV-related Anal Health Services
NCT04462042Not ApplicableRecruitingPrimary
Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma
NCT03870607Phase 2UnknownPrimary
Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)
Showing all 3 trials